BNTX — BIONTECH SE

Ownership history in GSK plc  ·  1 quarter on record

This page tracks every 13F SEC filing in which GSK plc reported a position in BIONTECH SE (BNTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
10.6% (2025 Q4)
Avg. % of fund
10.6%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 889,824 — — 10.60% $84.7M $95.20
% of Fund (quarterly)    BNTX price (monthly, adj. close)

Other funds also holding BNTX

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 3.35% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 2.21% Crocodile Capital Partners GmbH 3Y 1.68% FLOSSBACH VON STORCH SE 3Y 7Y 1.58% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 1.31% Long Focus Capital Management, LLC 3Y 1.27% GARDNER LEWIS ASSET MANAGEMENT L P 3Y 7Y 1.19% CenterBook Partners LP 3Y 1.1% Baader Bank Aktiengesellschaft 3Y 0.99% Privium Fund Management B.V. 3Y 0.58%
← Back to GSK plc Holdings